ACTN3 R577X polymorphism in marathon athletes

dc.contributor.authorGaratachea, Nuria
dc.contributor.authorFiuza Luces, María del Carmen
dc.contributor.authorMarín-Peiró, María
dc.contributor.authorReyes, A.
dc.contributor.authorSantos-Lozano, Alejandro
dc.contributor.authorLucía Mulas, Alejandro
dc.date.accessioned2014-11-28T10:08:17Z
dc.date.available2014-11-28T10:08:17Z
dc.date.issued2014spa
dc.description.abstractThe effect of ACTN3 has mainly been studied in elite athletes, bades on the hypothesis that its influence on muscle function would be most readily observable at the extremes of human performance. The main purpose of this study was to examine the association of ACTN3 with marathon performance across a wide range of competition levels.spa
dc.description.filiationUEMspa
dc.description.impact0.146 SJR (2014) Q4, 199/231 Health (social science), 131/169 Physical therapy, sports therapy and rehabilitation, 119/128 Sports sciencesspa
dc.identifier.citationGaratachea, N., Fiuza-Luces, M. C., Marín, M., Reyes, A., Santos-Lozano, A., & Lucía-Mulas, A. (2014). ACTN3 R577X polymorphism in marathon athlete. In J. L. Mendoza-Pérez, S. J. Fleck, P. E. Alcaraz, & A. Sánchez-Pato (Eds.), CCD: Cultura, Ciencia y Deporte, 9(25 Sup). NSCA 2014: 4th International Conference on Human Performance Development through Strength and Conditioning, June 26-28 2014. Murcia, Spain.spa
dc.identifier.issn16965043spa
dc.identifier.urihttp://hdl.handle.net/11268/3746
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsrestricted accessspa
dc.subject.uemEjerciciospa
dc.subject.uemGenéticaspa
dc.subject.uemMaratón - Atletismospa
dc.subject.unescoCienciaspa
dc.subject.unescoDeportespa
dc.subject.unescoGenética humanaspa
dc.titleACTN3 R577X polymorphism in marathon athletesspa
dc.typeconference outputspa
dspace.entity.typePublication
relation.isAuthorOfPublicationd3691359-d7bd-4a12-b84e-338e28c81f9f
relation.isAuthorOfPublication.latestForDiscoveryd3691359-d7bd-4a12-b84e-338e28c81f9f

Files